HDL Therapeutics

HDL Therapeutics is a medical device company developing cardiovascular therapeutic devices aimed at combating heart disease. We are at the forefront of science, providing future therapies for cardiovascular, neurodegenerative, autoimmune, viral, and peripheral vascular diseases. Our mission is to fill a critical gap in treatment options for patients with severe atherosclerotic disease through breakthrough therapies that harness the power of HDL to reverse (not just manage) atherosclerosis.